| Pathway ID | hsa05202 |
| Pathway Term | Transcriptional misregulation in cancer |
| Pathway Source | KEGG |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
ASPSCR1 | alveolar soft part sarcoma chromosome region, candidate 1 |
79058 | Q9BZE9 | chr17: 81,976,807-82,017,406 |
ATF1 | activating transcription factor 1 |
466 | P18846 | chr12: 50,763,710-50,821,122 |
BCL6 | B-cell CLL/lymphoma 6 |
604 | P41182 | chr3: 187,721,377-187,745,727 |
BIRC3 | baculoviral IAP repeat containing 3 |
330 | Q13489 | chr11: 102,317,450-102,339,403 |
BMP2K | BMP2 inducible kinase |
55589 | Q9NSY1 | chr4: 78,776,342-78,916,372 |
CCNA1 | cyclin A1 |
8900 | P78396 | chr13: 36,431,520-36,442,882 |
CCND2 | cyclin D2 |
894 | P30279 | chr12: 4,273,772-4,305,350 |
CCNT1 | cyclin T1 |
904 | O60563 | chr12: 48,688,458-48,716,998 |
CCNT2 | cyclin T2 |
905 | O60583 | chr2: 134,918,235-134,959,342 |
CD14 | CD14 molecule |
929 | P08571 | chr5: 140,631,728-140,633,701 |
CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
1026 | P38936 | chr6: 36,676,460-36,687,339 |
CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
1027 | P46527 | chr12: 12,715,058-12,722,371 |
CDKN2C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
1031 | P42773 | chr1: 50,960,745-50,974,633 |
CEBPB | CCAAT/enhancer binding protein (C/EBP), beta |
1051 | P17676 | chr20: 50,190,734-50,192,689 |
CSF1R | colony stimulating factor 1 receptor |
1436 | P07333 | chr5: 150,053,291-150,113,372 |
CXCL8 | chemokine (C-X-C motif) ligand 8 |
3576 | P10145 | chr4: 73,740,506-73,743,716 |
DDIT3 | DNA damage inducible transcript 3 |
1649 | P35638 | chr12: 57,516,588-57,520,517 |
DDX5 | DEAD (Asp-Glu-Ala-Asp) box helicase 5 |
1655 | P17844 | chr17: 64,499,616-64,508,199 |
DUSP6 | dual specificity phosphatase 6 |
1848 | Q16828 | chr12: 89,347,232-89,353,271 |
ETV1 | ets variant 1 |
2115 | P50549 | chr7: 13,891,228-13,991,425 |
ETV5 | ets variant 5 |
2119 | P41161 | chr3: 186,046,308-186,110,318 |
EWSR1 | EWS RNA binding protein 1 |
2130 | Q01844 | chr22: 29,268,009-29,300,525 |
FCGR1A | Fc fragment of IgG, high affinity Ia, receptor (CD64) |
2209 | P12314 | chr1: 149,782,671-149,792,518 |
FOXO1 | forkhead box O1 |
2308 | Q12778 | chr13: 40,469,953-40,666,597 |
FUS | FUS RNA binding protein |
2521 | P35637 | chr16: 31,180,110-31,194,871 |
FUT8 | fucosyltransferase 8 (alpha (1,6) fucosyltransferase) |
2530 | Q9BYC5 | chr14: 65,410,592-65,744,121 |
H3F3A | H3 histone, family 3A |
3020 | P84243 | chr1: 226,061,851-226,072,001 |
HDAC1 | histone deacetylase 1 |
3065 | Q13547 | chr1: 32,292,086-32,333,635 |
HDAC2 | histone deacetylase 2 |
3066 | Q92769 | chr6: 113,933,028-114,011,308 |
HHEX | hematopoietically expressed homeobox |
3087 | Q03014 | chr10: 92,689,951-92,695,646 |
HIST1H3D | histone cluster 1 H3 family member d |
8351 | P68431 | chr6: 26,195,595-26,199,293 |
HMGA2 | high mobility group AT-hook 2 |
8091 | P52926 | chr12: 65,824,131-65,966,295 |
HOXA10 | homeobox A10 |
3206 | P31260 | chr7: 27,170,591-27,180,261 |
HOXA9 | homeobox A9 |
3205 | P31269 | chr7: 27,162,435-27,175,180 |
HPGD | hydroxyprostaglandin dehydrogenase 15-(NAD) |
3248 | P15428 | chr4: 174,490,177-174,523,154 |
ID2 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
3398 | Q02363 | chr2: 8,678,845-8,684,453 |
IGF1 | insulin like growth factor 1 |
3479 | P05019 | chr12: 102,395,867-102,480,645 |
IGF1R | insulin like growth factor 1 receptor |
3480 | P08069 | chr15: 98,648,971-98,964,530 |
IGFBP3 | insulin like growth factor binding protein 3 |
3486 | P17936 | chr7: 45,912,245-45,921,874 |
IL1R2 | interleukin 1 receptor, type II |
7850 | P27930 | chr2: 101,991,844-102,028,544 |
IL6 | interleukin 6 |
3569 | P05231 | chr7: 22,725,884-22,732,002 |
ITGAM | integrin subunit alpha M |
3684 | P11215 | chr16: 31,259,990-31,332,892 |
JMJD1C | jumonji domain containing 1C |
221037 | Q15652 | chr10: 63,167,221-63,521,850 |
JUP | junction plakoglobin |
3728 | P14923 | chr17: 41,754,604-41,786,931 |
KDM6A | lysine (K)-specific demethylase 6A |
7403 | O15550 | chrX: 44,873,177-45,112,602 |
KLF3 | Kruppel-like factor 3 (basic) |
51274 | P57682 | chr4: 38,664,196-38,701,042 |
LMO2 | LIM domain only 2 |
4005 | P25791 | chr11: 33,858,576-33,892,289 |
MAF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog |
4094 | O75444 | chr16: 79,585,843-79,600,714 |
MDM2 | MDM2 proto-oncogene, E3 ubiquitin protein ligase |
4193 | Q00987 | chr12: 68,808,176-68,850,686 |
MEF2C | myocyte enhancer factor 2C |
4208 | Q06413 | chr5: 88,717,117-88,904,257 |
MEIS1 | Meis homeobox 1 |
4211 | O00470 | chr2: 66,433,452-66,573,869 |
MET | MET proto-oncogene, receptor tyrosine kinase |
4233 | P08581 | chr7: 116,672,390-116,798,386 |
MMP9 | matrix metallopeptidase 9 |
4318 | P14780 | chr20: 46,008,908-46,016,561 |
MPO | myeloperoxidase |
4353 | P05164 | chr17: 58,269,856-58,280,935 |
MYC | v-myc avian myelocytomatosis viral oncogene homolog |
4609 | P01106 | chr8: 127,735,434-127,741,434 |
MYCN | v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog |
4613 | P04198 | chr2: 15,940,564-15,947,007 |
NCOR1 | nuclear receptor corepressor 1 |
9611 | O75376 | chr17: 16,029,157-16,218,185 |
NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
4790 | P19838 | chr4: 102,501,329-102,617,302 |
NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta |
64332 | Q9BYH8 | chr3: 101,827,991-101,861,022 |
NGFR | nerve growth factor receptor |
4804 | P08138 | chr17: 49,495,293-49,515,017 |
NR4A3 | nuclear receptor subfamily 4 group A member 3 |
8013 | Q92570 | chr9: 99,821,855-99,866,891 |
NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 |
4914 | P04629 | chr1: 156,815,640-156,881,850 |
NUPR1 | nuclear protein 1, transcriptional regulator |
26471 | O60356 | chr16: 28,532,708-28,539,174 |
PAX8 | paired box 8 |
7849 | Q06710 | chr2: 113,215,997-113,278,950 |
PBX1 | pre-B-cell leukemia homeobox 1 |
5087 | P40424 | chr1: 164,555,584-164,899,296 |
PDGFA | platelet-derived growth factor alpha polypeptide |
5154 | P04085 | chr7: 497,258-520,296 |
PLAT | plasminogen activator, tissue |
5327 | P00750 | chr8: 42,175,233-42,207,724 |
PLAU | plasminogen activator, urokinase |
5328 | P00749 | chr10: 73,909,177-73,917,497 |
PPARG | peroxisome proliferator-activated receptor gamma |
5468 | P37231 | chr3: 12,287,368-12,434,356 |
PTCRA | pre T-cell antigen receptor alpha |
171558 | Q6ISU1 | chr6: 42,915,989-42,925,835 |
PTK2 | protein tyrosine kinase 2 |
5747 | Q05397 | chr8: 140,657,900-141,002,216 |
REL | v-rel avian reticuloendotheliosis viral oncogene homolog |
5966 | Q04864 | chr2: 60,881,521-60,931,610 |
RELA | v-rel avian reticuloendotheliosis viral oncogene homolog A |
5970 | Q04206 | chr11: 65,653,596-65,663,094 |
RUNX1 | runt-related transcription factor 1 |
861 | Q01196 | chr21: 34,787,801-36,004,667 |
RUNX2 | runt-related transcription factor 2 |
860 | Q13950 | chr6: 45,328,157-45,664,349 |
RXRB | retinoid X receptor beta |
6257 | P28702 | chr6: 33,193,588-33,200,688 |
SMAD1 | SMAD family member 1 |
4086 | Q15797 | chr4: 145,481,194-145,558,079 |
SUPT3H | SPT3 homolog, SAGA and STAGA complex component |
8464 | O75486 | chr6: 44,809,317-45,377,953 |
TAF15 | TATA-box binding protein associated factor 15 |
8148 | Q92804 | chr17: 35,713,791-35,864,615 |
TCF3 | transcription factor 3 |
6929 | P15923 | chr19: 1,609,290-1,652,605 |
TGFBR2 | transforming growth factor beta receptor II |
7048 | P37173 | chr3: 30,606,502-30,694,142 |
TP53 | tumor protein p53 |
7157 | P04637 | chr17: 7,661,779-7,687,550 |
TRAF1 | TNF receptor associated factor 1 |
7185 | Q13077 | chr9: 120,902,393-120,929,173 |
TSPAN7 | tetraspanin 7 |
7102 | P41732 | chrX: 38,561,370-38,688,920 |
UTY | ubiquitously transcribed tetratricopeptide repeat containing, Y-linked |
7404 | O14607 | chrY: 13,248,379-13,480,673 |
WHSC1 | Wolf-Hirschhorn syndrome candidate 1 |
7468 | O96028 | chr4: 1,871,424-1,982,207 |
WT1 | Wilms tumor 1 |
7490 | P19544 | chr11: 32,387,775-32,435,630 |
ZBTB16 | zinc finger and BTB domain containing 16 |
7704 | Q05516 | chr11: 114,059,593-114,250,676 |
ZBTB17 | zinc finger and BTB domain containing 17 |
7709 | Q13105 | chr1: 15,941,869-15,976,132 |
ZEB1 | zinc finger E-box binding homeobox 1 |
6935 | P37275 | chr10: 31,318,495-31,529,814 |